October 1, 2024

Figure S11 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer

Los puntos clave no están disponibles para este artículo en este momento.

RP-6306 treatment did not restore the sensitivity of T47D Palbo-R cells to palbociclib

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Chen et al. (Tue,) studied this question.

Preguntar a la IA

Me gusta

Guardar